Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Statistics in Medicine|October 2, 2015
Extending DerSimonian and Laird's methodology to perform network meta-analyses with random inconsistency effectsDan Jackson, Martin Law, Jessica K Barrett, et al.
Frontiers in Molecular Neuroscience|September 4, 2024
C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repairMaria B Goncalves, Yue Wu, Earl Clarke, et al.
BMC Medicine|March 2, 2018
Adaptive designs in clinical trials: why use them, and how to run and report themPhilip Pallmann, Alun W Bedding, Babak Choodari-Oskooei, et al.
JCI Insight|October 5, 2018
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetesEleonora Seelig, James Howlett, Linsey Porter, et al.
BMC Medicine|November 17, 2018
Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive designMunyaradzi Dimairo, Elizabeth Coates, Philip Pallmann, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 9, 2018
Editor's Choice - The Implications of Non-compliance to Endovascular Aneurysm Repair Surveillance: A Systematic Review and Meta-analysisMatthew Joe Grima, Mourad Boufi, Martin Law, et al.
BMJ (Clinical Research Ed.)|June 20, 2020
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive designMunyaradzi Dimairo, Philip Pallmann, James Wason, et al.
Trials|June 18, 2020
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive designMunyaradzi Dimairo, Philip Pallmann, James Wason, et al.
The Lancet. Oncology|March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
Trials|February 26, 2025
Guidelines for the content of statistical analysis plans in clinical trials: protocol for an extension to cluster randomized trialsKarla Hemming, Jacqueline Y Thompson, Richard L Hooper, et al.
Pageof 14